Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS

A. Burgetova, P. Dusek, T. Uher, M. Vaneckova, M. Vejrazka, R. Burgetova, D. Horakova, B. Srpova, M. Kalousova, L. Noskova, K. Levova, J. Krasensky, L. Lambert

. 2023 ; 24 (12) : . [pub] 20230612

Language English Country Switzerland

Document type Journal Article

Grant support
MH CZ-DRO, General University Hospital in Prague-VFN, 00064165 Ministry of Health of the Czech Republic
NV18-08-00062 Ministry of Health of the Czech Republi
Cooperatio, Medical Diagnostics and Basic Medical Sciences, Neuroscience Charles University in Prague
National Institute for Neurological Research, Programme EXCELES, ID Project No. LX22NPO5107 European Union
reg. no. LM2023033 BBMRI.cz
n/A Roche

In this prospective longitudinal study, we quantified regional brain volume and susceptibility changes during the first two years after the diagnosis of multiple sclerosis (MS) and identified their association with cerebrospinal fluid (CSF) markers at baseline. Seventy patients underwent MRI (T1 and susceptibility weighted images processed to quantitative susceptibility maps, QSM) with neurological examination at the diagnosis and after two years. In CSF obtained at baseline, the levels of oxidative stress, products of lipid peroxidation, and neurofilaments light chain (NfL) were determined. Brain volumetry and QSM were compared with a group of 58 healthy controls. In MS patients, regional atrophy was identified in the striatum, thalamus, and substantia nigra. Magnetic susceptibility increased in the striatum, globus pallidus, and dentate and decreased in the thalamus. Compared to controls, MS patients developed greater atrophy of the thalamus, and a greater increase in susceptibility in the caudate, putamen, globus pallidus and a decrease in the thalamus. Of the multiple calculated correlations, only the decrease in brain parenchymal fraction, total white matter, and thalamic volume in MS patients negatively correlated with increased NfL in CSF. Additionally, negative correlation was found between QSM value in the substantia nigra and peroxiredoxin-2, and QSM value in the dentate and lipid peroxidation levels.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011067
003      
CZ-PrNML
005      
20240903112358.0
007      
ta
008      
230718s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms241210048 $2 doi
035    __
$a (PubMed)37373196
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Burgetova, Andrea $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000299752338 $7 xx0163957
245    10
$a CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS / $c A. Burgetova, P. Dusek, T. Uher, M. Vaneckova, M. Vejrazka, R. Burgetova, D. Horakova, B. Srpova, M. Kalousova, L. Noskova, K. Levova, J. Krasensky, L. Lambert
520    9_
$a In this prospective longitudinal study, we quantified regional brain volume and susceptibility changes during the first two years after the diagnosis of multiple sclerosis (MS) and identified their association with cerebrospinal fluid (CSF) markers at baseline. Seventy patients underwent MRI (T1 and susceptibility weighted images processed to quantitative susceptibility maps, QSM) with neurological examination at the diagnosis and after two years. In CSF obtained at baseline, the levels of oxidative stress, products of lipid peroxidation, and neurofilaments light chain (NfL) were determined. Brain volumetry and QSM were compared with a group of 58 healthy controls. In MS patients, regional atrophy was identified in the striatum, thalamus, and substantia nigra. Magnetic susceptibility increased in the striatum, globus pallidus, and dentate and decreased in the thalamus. Compared to controls, MS patients developed greater atrophy of the thalamus, and a greater increase in susceptibility in the caudate, putamen, globus pallidus and a decrease in the thalamus. Of the multiple calculated correlations, only the decrease in brain parenchymal fraction, total white matter, and thalamic volume in MS patients negatively correlated with increased NfL in CSF. Additionally, negative correlation was found between QSM value in the substantia nigra and peroxiredoxin-2, and QSM value in the dentate and lipid peroxidation levels.
650    _2
$a lidé $7 D006801
650    _2
$a prospektivní studie $7 D011446
650    _2
$a longitudinální studie $7 D008137
650    _2
$a železo $7 D007501
650    _2
$a mozek $x diagnostické zobrazování $x patologie $7 D001921
650    12
$a roztroušená skleróza $x diagnostické zobrazování $x patologie $7 D009103
650    12
$a nemoci centrálního nervového systému $x patologie $7 D002493
650    _2
$a magnetická rezonanční tomografie $x metody $7 D008279
650    _2
$a oxidační stres $7 D018384
650    _2
$a atrofie $x patologie $7 D001284
650    _2
$a šedá hmota $x patologie $7 D066128
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dusek, Petr $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic $u Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000348779642 $7 jo2013795390
700    1_
$a Uher, Tomas $u Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000331609022 $7 xx0189534
700    1_
$a Vaneckova, Manuela $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic
700    1_
$a Vejrazka, Martin $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic
700    1_
$a Burgetova, Romana $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic $u Department of Radiology, Third Faculty of Medicine, Charles University, 100 34 Prague, Czech Republic
700    1_
$a Horakova, Dana $u Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic
700    1_
$a Srpová, Barbora $u Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000280926625 $7 xx0321726
700    1_
$a Kalousova, Marta $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic
700    1_
$a Noskova, Libuse $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic
700    1_
$a Levova, Katerina $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000299956613 $7 xx0271128
700    1_
$a Krasensky, Jan $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic
700    1_
$a Lambert, Lukas $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000322994707 $7 xx0145830
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 24, č. 12 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37373196 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20240903112355 $b ABA008
999    __
$a ok $b bmc $g 1963462 $s 1197332
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 24 $c 12 $e 20230612 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a MH CZ-DRO, General University Hospital in Prague-VFN, 00064165 $p Ministry of Health of the Czech Republic
GRA    __
$a NV18-08-00062 $p Ministry of Health of the Czech Republi
GRA    __
$a Cooperatio, Medical Diagnostics and Basic Medical Sciences, Neuroscience $p Charles University in Prague
GRA    __
$a National Institute for Neurological Research, Programme EXCELES, ID Project No. LX22NPO5107 $p European Union
GRA    __
$a reg. no. LM2023033 $p BBMRI.cz
GRA    __
$a n/A $p Roche
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...